Change powers and duties of health directors in certain local public health departments and provide requirements relating to community-wide directed health measures

109th Legislature (2025-2026) Introduced by Kathleen Kauth

LB 203 requires elected officials' written pre-approval and board ratification for community-wide health measures, with AM611 capping CHMs at 7 days unless renewed.

Enrollment and Review ER103 adopted

Purpose and intent

To define key terms and require democratic oversight by locally elected officials for community-wide directed health measures (CHMs).

To clarify the role of health directors in issuing CHMs while ensuring boards of health have formal review and ratification steps.

To introduce time limits on CHMs, via an amendment (AM611), limiting how long a CHM can run without board action.

Key provisions and changes

Definitions (Sec. 1)

Community-wide directed health measure: a public health action affecting the total population of the jurisdiction when there are no known epidemiological links.

Epidemiological link: an exposure scenario where transmission is plausible; an exposure is linked if any part of the transmission chain includes a contact or confirmed/probable/suspect case.

Local public health department: county, district, or city-county health department.

These definitions set the scope for when a CHM can be considered “community-wide” and how exposure is understood.

Approval and issuance of CHMs (Sec. 2–3)

Health directors’ power to issue and enforce CHMs is retained but conditioned on written approval in advance.

Before issuance, a majority of publicly elected representatives (1) of the county board and (2) for city-county departments, the city council must approve CHMs in writing.

CHMs must be submitted to the respective board of health for ratification at the next regularly scheduled meeting.

The bill removes the requirement that measures must “arrest the progress of the disease” as part of adoption criteria.

Repealer (Sec. 4)

Repealer language related to previous structures is included, with the substantive changes governed by the new provisions above.

Amendment (AM611) – additional CHM controls

A new provision: CHMs are subject to approval by the local board of health.

CHMs expire 7 days after issuance unless reauthorized.

Reauthorization requires approval by the local board of health.

Who is affected

Local health directors in county, district, and city-county health departments.

County boards and city councils (as the elected bodies required to approve CHMs).

Local boards of health (as the ratifying/reauthorizing body for CHMs).

The general public within the jurisdiction where CHMs would apply (via the CHMs themselves).

Procedural and timeline aspects

Introduced: January 14, 2025.

Hearings: February 7, 2025.

Committee action: Health and Human Services advanced LB 203 to General File with AM611 (amendment added).

Status: Placed on General File with AM611 (as of March 18, 2025).

Notable process change: CHMs require written approval by elected officials before issuance and board ratification afterward; with AM611, CHMs have a 7-day duration unless renewed by the board.

Stakeholders

Supporters and opponents were represented in committee testimony, including local health departments, advocacy groups, and professional associations. The bill is framed as increasing democratic oversight while clarifying the scope of CHMs.

This summary highlights the bill’s core changes: definitional groundwork for CHMs, required elected-official approval before issuance, board ratification, and a new 7-day expiration window under AM611, all shaping how local public health directors can act in public health emergencies.

Bill